Comparison of Effects of Valsartan and Amlodipine on Cognitive Functions and Auditory P300 Event-Related Potentials in Elderly Hypertensive Patients

Eiichi Katada, Norihiko Uematsu, Yuko Takuma, Noriyuki Matsukawa

Clinical Neuropharmacology · 2014 · 12 citations · 9 references

Concepts

Abstract

OBJECTIVE: We compared the antihypertensive effect of valsartan (VAL) and amlodipine (AML) treatments in elderly hypertensive patients by examining the long-term changes in cognitive function and auditory P300 event-related potentials. METHODS: We enrolled 20 outpatients, including 12 men and 8 women in the age group of 56 to 81 years who had mild to moderate essential hypertension. The subjects were randomly allocated to receive either 80 mg VAL once a day (10 patients) or 5 mg AML once a day (10 patients). Neuropsychological assessment and auditory P300 event-related potentials were obtained before initiation of VAL or AML treatment and after 6 months of the treatment with VAL or AML. Neuropsychological assessment was evaluated by conducting the Mini-Mental State Examination, the verbal fluency, word-list memory, word-list recall test, word-list recognition, and Trails B tests. RESULTS: Both the groups showed significantly reduced-blood pressure after 6 months of treatment, and the intergroup difference was not significant. The mean baseline Mini-Mental State Examination scores of the VAL and AML groups were not significantly different. Amlodipine treatment did not significantly affect any test score, but VAL treatment significantly increased the word-list memory and word-list recall test scores. Valsartan, and not AML, significantly reduced the mean P300 latency after 6 months. CONCLUSIONS: These results suggest that VAL exerts a positive effect on cognitive functions, independent of its antihypertensive effect.

References

9